The University of Texas M.D Anderson Cancer Ceneter (MDACC) — Houston, Texas

The University of Texas M.D Anderson Cancer Ceneter (MDACC) is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

The University of Texas M.D Anderson Cancer Ceneter (MDACC) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: iO Resistant sqNSCLC.

Sponsors: Fortvita Biologics (USA)Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The University of Texas M.D Anderson Cancer Ceneter (MDACC)?

The University of Texas M.D Anderson Cancer Ceneter (MDACC) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The University of Texas M.D Anderson Cancer Ceneter (MDACC) conducted?

The University of Texas M.D Anderson Cancer Ceneter (MDACC) has 1 clinical trials on record, with 1 currently active. Their work covers iO Resistant sqNSCLC.

Is The University of Texas M.D Anderson Cancer Ceneter (MDACC) accredited by Crixeo Health?

The University of Texas M.D Anderson Cancer Ceneter (MDACC) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The University of Texas M.D Anderson Cancer Ceneter (MDACC)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.